Building definitional consensus in palliative care

2021 ◽  
pp. 35-43
Author(s):  
Russell K. Portenoy

Definitional inconsistencies and confusion about core principles and practices have been part of the history of palliative care for more than five decades. The term ‘palliative care’ was first used to describe clinical services that had a singular focus on end of life care, particularly in the context of cancer; the ‘good death’ was its definitional touchstone. Modern use of the term ‘hospice’ predated this label and described services with the same intent, and ‘supportive care’, a term that emerged decades later, referenced elements that were comparable. Over time, the use of these labels evolved, and although global consensus has not yet been achieved, the development of palliative care as a clinical discipline has promoted greater agreement. Specialists increasingly favour the use of ‘palliative care’ to depict a multiprofessional model of care appropriate for all populations with potentially life-limiting chronic illnesses, the goal of which is to enhance the potential for a satisfactory quality of life and end of life experience by preventing or managing the suffering and illness burden of the patient and family. Around the world, specialists use both ‘palliative care’ and ‘hospice’ to describe programmes that advance the objectives of palliative care; ‘hospice’ is usually preferred when programmes serve those with advanced illness and short prognosis in a home-like environment. ‘Supportive care’ is generally applied to a parallel oncology-based model with a strong focus on problems related to cancer treatment. As specialist palliative care programmes are continuing to emerge globally, expansion of the model of care is occurring through early integration approaches that include the efforts of non-specialists. This chapter discusses the evolving perspectives on the definitions applied to palliative care and related terms, and the core principles and practices that have supported its global development.

2018 ◽  
pp. bmjspcare-2018-001630 ◽  
Author(s):  
Louise Purtell ◽  
P Marcin Sowa ◽  
Ilse Berquier ◽  
Carla Scuderi ◽  
Carol Douglas ◽  
...  

ObjectivesFor many people with advanced kidney disease, their physical, psychological and emotional needs remain unmet. Kidney supportive care, fully integrating specialist kidney and palliative care teams, responds to the emotional and symptom distress in this cohort who may be on a non-dialysis care pathway or on dialysis and approaching end of life. We aimed to analyse and describe the operation and patient characteristics of a new kidney supportive care programme (KSCp).MethodsA multidisciplinary KSCp was introduced through a tertiary hospital in Brisbane, Australia. Operational information and characteristics of referred patients were collected from internal databases and electronic medical records and analysed descriptively. Patient data were collected using validated instruments to assess symptom burden, health-related quality of life, health state, functional status and performance at clinic entry and analysed descriptively.Results129 people with advanced kidney disease were referred to the KSCp within the first year (median age 74 (range 27.7–90.5), 48.1% female, median Charlson Comorbidity Index score 7 (IQR 6–8) and mean Integrated Palliative care Outcome Scale Renal score 19.6±9.8). 59% were currently receiving dialysis. The leading reason for referral was symptom management (37%). While quality of life and health state varied considerably among the cohort, in general, these parameters were well below population norms.ConclusionsResults indicate that patients referred to the KSCp were those with a strong need for a patient-centred, integrated model of care. Shifting focus to co-ordinated, multidisciplinary care rather than discrete specialty silos appears key to addressing the challenging clinical problems in end-of-life care.


2017 ◽  
Vol 35 (31_suppl) ◽  
pp. 67-67
Author(s):  
Adi Joseph Klil-Drori ◽  
Karine Silva ◽  
Tracy Regimbald ◽  
Sarit E. Assouline

67 Background: ASCO endorses early integration of palliative care in the treatment of patients with advanced cancers and encourages patient education with regards to prognosis and participation in medical decision making. We implemented a uniform process of discussing end of life and advance directives (AD) early in the course of experimental cancer treatment and assessed whether this process is aligned with our patients' perspectives. Methods: This was a pilot study in a research unit conducting early-phase trials for patients with no remaining standard of care. Accrual goal was 15 patients in four months. We identified patients with advanced malignancies who were screened for cancer trials and approached their physicians with a request to fill out an AD form in discussion with their patients. Upon initiation of treatment, we filled out a supportive care checklist for each patient. The patients filled out a structured questionnaire probing their views on end-of-life discussion and awareness to supportive care resources on cycle 2 day 1 (Q1) and on cycle 3 day 1 (Q2). Results: Out of 41 screened, we completed checklists for 36 patients. Of these, 26 filled out Q1 and 11 filled out Q1 + Q2. Response rate to the questionnaires was 100%. The patients were diagnosed with metastatic solid tumor (23) and hematologic malignancies (3) and had 2 (0-5) previous lines of treatment. Females and males were 14 and 12, respectively. AD forms were filled out in most patients (81%), but about half (54%) reported having had AD discussions with their physicians. Most patients (73%) were aware of supportive resources (palliative care, social worker, support groups), and most (62%) actually used them while on study. Agreement in Q1 and Q2 was comparable (Table), with some rise in agreement with the timing of AD discussion. Conclusions: In the context of treatment on clinical trials, a large-scale initiative is feasible. More patients agree with time that early discussion of AD meets their goals while almost half report having had no such discussion with their physicians. [Table: see text]


Author(s):  
Mellar P. Davis ◽  
Eduardo Bruera ◽  
Daniel Morganstern

Palliative care has become synonymously associated with hospice care in the minds of patients and physicians. Supportive care is a more acceptable term and leads to earlier referral. Miscommunication and a “collusion of hope” centered on cancer treatment is detrimental to care at the end of life and results in complicated bereavement. Patients, despite being told prognosis, may not comprehend the news even if delivered in an empathetic manner. There are resource and policy barriers to palliative care. However, integration of palliative care early in the management of advanced cancer has demonstrated multiple benefits without reducing survival.


2014 ◽  
Vol 6 (2) ◽  
pp. 227-245
Author(s):  
Daniela Moşoiu

Abstract Persons suffering from chronic and life limiting illnesses often have unrelieved symptoms such as pain, depression, fatigue, and psychosocial and spiritual distress. In Romania they are frequently left in the care of their families with little support from the health care system. It seems a paradox that those who are the sickest persons in a country find little place in the health care system. This article presents palliative care as a solution to the suffering for these patients and their families by describing the concept, models of services, its beneficiaries and benefits and presenting the history of development of hospice and palliative care worldwide and in Romania.


Author(s):  
Areeba Jawed ◽  
Joseph D. Rotella

Patients with chronic kidney disease typically have needs that cut across a range of services, including nephrology, other specialties, primary care, and palliative care. This chapter proposes a model of integrated supportive care from diagnosis to end of life that coordinates the efforts and maximizes the benefits of different healthcare teams. Supportive care teams can learn primary kidney supportive care skills to manage symptoms, provide emotional support, and facilitate conversations that focus on what matters most to patients and families. Applying best practices of care coordination, they can facilitate seamless transitions as the patient’s condition evolves.


2003 ◽  
Vol 1 (1) ◽  
pp. 1-2 ◽  
Author(s):  
William Breitbart

We are extremely proud and gratified to present the inaugural issue of our new international palliative care journal, Palliative & Supportive Care (P&SC). P&SC is the first international journal of palliative medicine that focuses on the psychiatric, psychosocial, spiritual, existential, ethical, philosophical, and humanities aspects of palliative care. The journal's aim is to serve as an educational resource for practitioners from a wide array of disciplines engaged in the delivery of care to those with life-threatening illnesses along the entire continuum of care, from diagnosis to the end of life. The journal also seeks to both stimulate and provide a forum for research in the psychiatric, psychosocial, and spiritual components of palliative care.


Author(s):  
E. Alessandra Strada

This chapter describes palliative psychology competencies in the seventh domain of palliative care, which addresses palliative care for the patient approaching end of life and the patient’s family. The medical context of dying is reviewed by discussing the interplay of psychological and medical factors related to approaching death and the dying process. The physiological and psychological changes expected in advanced illness and during the dying process are also discussed. The chapter presents a role for the palliative psychologist at different junctures during advanced illness and the dying process. Complications that may arise during the dying process, including hemorrhage and agitated delirium, are discussed and psychological interventions that can promote safety and comfort for the patient and the family are described.


2015 ◽  
Vol 33 (29_suppl) ◽  
pp. 36-36
Author(s):  
Cheruppolil R. Santhosh-Kumar ◽  
Deborah Gray ◽  
Stephanie Struve ◽  
Carol Huibregtse

36 Background: Integrating early palliative care with cancer treatment improves quality of life and survival. Effective communication among physicians, patients and their loved ones is crucial to end-of-life, hospice and palliative care discussions. To address the inherent challenges in these discussions, we implemented a structured outpatient palliative care family conference (OFC) program at our community cancer clinic. Methods: A team comprising a hematologist/oncologist, cancer nurse navigator and social worker developed a toolkit for conducting an OFC, recognizing that each family conference is a unique adaptive challenge. New patients with advanced malignancies and limited life expectancy (<12 months) were offered a 90-minute structured OFC attended by the care team, patient and family members and or friends. Pre and post-conference patient satisfaction surveys and other data were collected prospectively. Results: From March 2014 through May 2015, fortyOFC were conducted (16 female and 24 male patients, median age: 67 years). Diagnoses were advanced gastrointestinal (14), lung (12), hematologic (6) and other (8) malignancies. As a direct result of the OFC program, 18 patients ordered do-not-resuscitate bracelets, 15 completed advanced directives, 7 submitted paperwork for disabled parking permits, 7 were referred to hospice and 4 for rehabilitation therapy. Further results are shown in the table. Conclusions: Structured outpatient palliative care family conferences improve satisfaction of end-of-life discussions and facilitate integration of palliative care options. Enhanced communication between providers, patients and loved ones eases the challenges of such discussions. The OFC approach could be a model for integrating palliative care in community cancer clinics. [Table: see text]


2016 ◽  
Vol 52 (6) ◽  
pp. e153
Author(s):  
Jude Emmanuel Cléophat ◽  
Catherine Gonthier ◽  
Pierre Gagnon ◽  
Ana Marin ◽  
Jocelyne Chiquette ◽  
...  

2020 ◽  
Author(s):  
Ellinor Christin Haukland ◽  
Christian von Plessen ◽  
Carsten Nieder ◽  
Barthold Vonen

Abstract Background: Anticancer treatment exposes patients to negative consequences such as increased toxicity and decreased quality of life, and there are clear guidelines recommending limiting use of aggressive anticancer treatments for patients near end of life. The aim of this study is to investigate the association between anticancer treatment given during the last 30 days of life and adverse events contributing to death and elucidate how adverse events can be used as a measure of quality and safety in end-of-life cancer care Methods: Retrospective cohort study of 247 deceased hospitalised cancer patients at three hospitals in Norway. The Global Trigger Tool method were used to identify adverse events. We used Poisson regression and binary logistic regression to compare adverse events and association with use of anticancer treatment given during the last 30 days of life. Results: 30 % of deceased hospitalised cancer patients received some kind of anticancer treatment during the last 30 days of life, mainly systemic anticancer treatment. These patients had 62 % more adverse events compared to patients not being treated last 30 days, 39 vs. 24 adverse events per 1 000 patient days (p<0.001, OR 1.62 (1.23 – 2.15). They also had twice the odds of an adverse event contributing to death compared to patients without such treatment, 33 vs. 18 % (p=0.045, OR 1.85 (1.01 – 3.36)). Receiving follow up by specialist palliative care reduced the rate of AEs per 1 000 patient days in both groups by 29 % (p= 0.02, IRR 0.71, CI 95% 0.53 – 0.96). Conclusions: Anticancer treatment given during the last 30 days of life is associated with a significantly increased rate of adverse events and related mortality. Patients receiving specialist palliative care had significantly fewer adverse events, supporting recommendations of early integration of palliative care in a patient safety perspective.


Sign in / Sign up

Export Citation Format

Share Document